146 related articles for article (PubMed ID: 3575349)
1. Facilitation of the expression but not the acquisition of latent inhibition by haloperidol in rats.
Weiner I; Feldon J; Katz Y
Pharmacol Biochem Behav; 1987 Feb; 26(2):241-6. PubMed ID: 3575349
[TBL] [Abstract][Full Text] [Related]
2. Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs.
Weiner I; Shadach E; Barkai R; Feldon J
Neuropsychopharmacology; 1997 Jan; 16(1):42-50. PubMed ID: 8981387
[TBL] [Abstract][Full Text] [Related]
3. The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli.
Feldon J; Weiner I
Biol Psychiatry; 1991 Apr; 29(7):635-46. PubMed ID: 2054435
[TBL] [Abstract][Full Text] [Related]
4. Disruption of latent inhibition by acute administration of low doses of amphetamine.
Weiner I; Lubow RE; Feldon J
Pharmacol Biochem Behav; 1988 Aug; 30(4):871-8. PubMed ID: 3227035
[TBL] [Abstract][Full Text] [Related]
5. Facilitation of latent inhibition by haloperidol in rats.
Weiner I; Feldon J
Psychopharmacology (Berl); 1987; 91(2):248-53. PubMed ID: 3107041
[TBL] [Abstract][Full Text] [Related]
6. Abolition of the acquisition but not the expression of latent inhibition by chlordiazepoxide in rats.
Feldon J; Weiner I
Pharmacol Biochem Behav; 1989 Jan; 32(1):123-7. PubMed ID: 2734324
[TBL] [Abstract][Full Text] [Related]
7. Phencyclidine does not disrupt latent inhibition in rats: implications for animal models of schizophrenia.
Weiner I; Feldon J
Pharmacol Biochem Behav; 1992 Aug; 42(4):625-31. PubMed ID: 1513845
[TBL] [Abstract][Full Text] [Related]
8. Dopamine manipulations limited to preexposure are sufficient to modulate latent inhibition.
Bethus I; Muscat R; Goodall G
Behav Neurosci; 2006 Jun; 120(3):554-62. PubMed ID: 16768607
[TBL] [Abstract][Full Text] [Related]
9. Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal.
Russig H; Murphy CA; Feldon J
Neuropsychopharmacology; 2002 Jun; 26(6):765-77. PubMed ID: 12007747
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of latent inhibition in the rat by the atypical antipsychotic agent remoxipride.
Trimble KM; Bell R; King DJ
Pharmacol Biochem Behav; 1997 Apr; 56(4):809-16. PubMed ID: 9130309
[TBL] [Abstract][Full Text] [Related]
11. Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus.
Ruob C; Elsner J; Weiner I; Feldon J
Behav Brain Res; 1997 Oct; 88(1):35-41. PubMed ID: 9401706
[TBL] [Abstract][Full Text] [Related]
12. Latent inhibition is disrupted by nucleus accumbens shell lesion but is abnormally persistent following entire nucleus accumbens lesion: The neural site controlling the expression and disruption of the stimulus preexposure effect.
Gal G; Schiller D; Weiner I
Behav Brain Res; 2005 Jul; 162(2):246-55. PubMed ID: 15970218
[TBL] [Abstract][Full Text] [Related]
13. The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin.
Shadach E; Gaisler I; Schiller D; Weiner I
Neuropsychopharmacology; 2000 Aug; 23(2):151-61. PubMed ID: 10882841
[TBL] [Abstract][Full Text] [Related]
14. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
Gaisler-Salomon I; Weiner I
Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
[TBL] [Abstract][Full Text] [Related]
15. The effects of phencyclidine on latent inhibition in taste aversion conditioning: differential effects of preexposure and conditioning.
Pålsson E; Klamer D; Wass C; Archer T; Engel JA; Svensson L
Behav Brain Res; 2005 Feb; 157(1):139-46. PubMed ID: 15617780
[TBL] [Abstract][Full Text] [Related]
16. Effects of microinjections of apomorphine and haloperidol into the inferior colliculus on the latent inhibition of the conditioned emotional response.
Melo LL; Pereira EC; Pagini CH; Coimbra NC; Brandão ML; Ferrari EA
Exp Neurol; 2009 Mar; 216(1):16-21. PubMed ID: 19084523
[TBL] [Abstract][Full Text] [Related]
17. The sigma ligand BMY-14802 as a potential antipsychotic: evidence from the latent inhibition model in rats.
Weiner I; Traub A; Rawlins JN; Smith AD; Feldon J
Behav Pharmacol; 1995 Jan; 6(1):46-54. PubMed ID: 11224311
[TBL] [Abstract][Full Text] [Related]
18. Haloperidol-induced potentiation of latent inhibition: interaction with parameters of conditioning.
Ruob C; Weiner I; Feldon J
Behav Pharmacol; 1998 May; 9(3):245-53. PubMed ID: 9832938
[TBL] [Abstract][Full Text] [Related]
19. Basolateral amygdala lesions in the rat produce an abnormally persistent latent inhibition with weak preexposure but not with context shift.
Schiller D; Weiner I
Behav Brain Res; 2005 Aug; 163(1):115-21. PubMed ID: 15921766
[TBL] [Abstract][Full Text] [Related]
20. Haloperidol and clozapine antagonise amphetamine-induced disruption of latent inhibition of conditioned taste aversion.
Russig H; Kovacevic A; Murphy CA; Feldon J
Psychopharmacology (Berl); 2003 Nov; 170(3):263-270. PubMed ID: 12898122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
